Content area
Full text
An infant [age and sex not stated] developed hypercalcaemia and high s-25-hydroxycholecalciferol (OHD) level following a colecalciferol [vitamin D3 product; route and duration of treatment to reaction onset not stated].
The infant received colecalciferol as supplementation. Subsequently, the infant developed severe hypercalcaemia and unmeasurable high s-25OHD...